title: Therapeutic efficacy and safety of undenatured type-II collagen (UC-II) alone or in combination with (-)-hydroxycitric acid and chromemate in arthritic dogs.
authors.affiliation: Toxicology Department, Murray State University, Hopkinsville/Murray, KY 42240, USA.
authors.forename: A
authors.initials: A
authors.lastname: Peal
authors.forename: M
authors.initials: M
authors.lastname: D'Altilio
authors.forename: C
authors.initials: C
authors.lastname: Simms
authors.forename: M
authors.initials: M
authors.lastname: Alvey
authors.forename: R C
authors.initials: RC
authors.lastname: Gupta
authors.forename: J T
authors.initials: JT
authors.lastname: Goad
authors.forename: T D
authors.initials: TD
authors.lastname: Canerdy
authors.forename: M
authors.initials: M
authors.lastname: Bagchi
authors.forename: D
authors.initials: D
authors.lastname: Bagchi
mesh_terms: D000284:Administration, Oral; D000818:Animals; D017608:Chromium Compounds / Q000008:administration & dosage; D002951:Citrates / Q000008:administration & dosage*; D024043:Collagen Type II / Q000008:administration & dosage*; D004283:Dog Diseases / Q000188:drug therapy* / Q000473:pathology; D004285:Dogs; D004359:Drug Therapy, Combination; D010003:Osteoarthritis / Q000188:drug therapy / Q000662:veterinary*; D010146:Pain / Q000517:prevention & control / Q000662:veterinary; D010147:Pain Measurement / Q000662:veterinary; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D017608:Chromium Compounds; D002951:Citrates; D024043:Collagen Type II; C007999:hydroxycitric acid